China Pharma Holding (STU:XQJ0) Accumulated other comprehensive income (loss) : €10.52 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is China Pharma Holding Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. China Pharma Holding's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2024 was €10.52 Mil.

China Pharma Holding's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2023 (€10.61 Mil) to Dec. 2023 (€10.50 Mil) but then increased from Dec. 2023 (€10.50 Mil) to Mar. 2024 (€10.52 Mil).

China Pharma Holding's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (€11.12 Mil) to Dec. 2022 (€10.93 Mil) and declined from Dec. 2022 (€10.93 Mil) to Dec. 2023 (€10.50 Mil).

China Pharma Holding Accumulated other comprehensive income (loss) Historical Data

The historical data trend for China Pharma Holding's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Pharma Holding Accumulated other comprehensive income (loss) Chart

China Pharma Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

10.42

10.15

11.12

10.93

10.50

China Pharma Holding Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															11.00	10.39	10.61	10.50	10.52

China Pharma Holding Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

China Pharma Holding Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of China Pharma Holding's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

China Pharma Holding (STU:XQJ0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Pharma Holding Inc (STU:XQJ0) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

CPHI:USA

Address

Second Floor, No. 17, Jinpan Road, Hainan Province, Haikou, CHN, 570216

Website

https://www.chinapharmaholdings.com

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

China Pharma Holding (STU:XQJ0) Headlines

No Headlines